EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease

Fang Lei, Qizhen Huang, Chengfeng Zhang, Youhui Lin, Yan Zhang, Faming Wang

Materials Today Bio · 2025-08 · 33 · 102008

DOI: 10.1016/j.mtbio.2025.102008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2025-08. Verfasst von Fang Lei und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Nantong University, Nantong, 226019, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gut that has caused an escalating burden on the global healthcare system in recent years. Researchers have been actively seeking innovative therapeutic strategies to combat this intractable disease. Recent advances in nanozyme technology have opened up new avenues for the development of novel therapeutic strategies for IBD. This review provides a comprehensive overview of the related works in the developments and applications of different nanozymes for IBD therapy. By overviewing the known pathogenesis of IBD and pathogenesis-guided applications of nanozymes in IBD therapy, this review highlights the opportunities for nanozyme-based strategies to address IBD via the underlying mechanisms. This review also examines the current state of nanozyme research in IBD, including the design and application of nanozymes, and discusses the challenges and future directions for this emerging field. In addition, by integrating the understanding of IBD pathogenesis with the development of nanozyme technology, this review aims to stimulate further research to uncover new opportunities for this debilitating disease.

Schlagwörter

Stichwörter der Autor:innen

Biomedical applicationInflammatory bowel diseaseMulti-enzyme activitiesNanozymePathogenetic factors

Autor:innen und Institutionen

  • School of Public Health, Nantong University, Nantong, 226019, China.
  • Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China.
  • Department of Physics, Xiamen University, Xiamen, 361005, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lei, F., Huang, Q., Zhang, C., Lin, Y., Zhang, Y., & Wang, F. (2025). Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease. Materials Today Bio, 33, 102008. https://doi.org/10.1016/j.mtbio.2025.102008

Vancouver

Lei F, Huang Q, Zhang C, Lin Y, Zhang Y, Wang F. Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease. Materials Today Bio. 2025;33:102008. doi:10.1016/j.mtbio.2025.102008

BibTeX
@article{Lei2025,
  author = {Lei, Fang and Huang, Qizhen and Zhang, Chengfeng and Lin, Youhui and Zhang, Yan and Wang, Faming},
  title = {Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease},
  journal = {Materials Today Bio},
  year = {2025},
  volume = {33},
  pages = {102008},
  doi = {10.1016/j.mtbio.2025.102008}
}
Kostenlos starten →